Plimoth Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414K | Sell |
788
-19
| -2% | -$9.98K | 0.1% | 125 |
|
|
2025
Q1 | $512K | Sell |
807
-30
| -4% | -$19K | 0.13% | 117 |
|
|
2024
Q4 | $596K | Hold |
837
| – | – | 0.15% | 108 |
|
|
2024
Q3 | $880K | Sell |
837
-71
| -8% | -$74.6K | 0.22% | 95 |
|
|
2024
Q2 | $954K | Sell |
908
-60
| -6% | -$63.1K | 0.25% | 85 |
|
|
2024
Q1 | $932K | Sell |
968
-164
| -14% | -$158K | 0.25% | 86 |
|
|
2023
Q4 | $994K | Sell |
1,132
-1,324
| -54% | -$1.16M | 0.29% | 81 |
|
|
2023
Q3 | $2.02M | Sell |
2,456
-188
| -7% | -$155K | 0.63% | 56 |
|
|
2023
Q2 | $1.9M | Sell |
2,644
-19
| -0.7% | -$13.7K | 0.57% | 60 |
|
|
2023
Q1 | $2.19M | Buy |
2,663
+40
| +2% | +$32.9K | 0.68% | 56 |
|
|
2022
Q4 | $1.89M | Sell |
2,623
-75
| -3% | -$54.1K | 0.61% | 59 |
|
|
2022
Q3 | $1.86M | Buy |
2,698
+206
| +8% | +$142K | 0.64% | 55 |
|
|
2022
Q2 | $1.47M | Buy |
2,492
+442
| +22% | +$261K | 0.46% | 70 |
|
|
2022
Q1 | $1.43M | Buy |
2,050
+13
| +0.6% | +$9.08K | 0.38% | 76 |
|
|
2021
Q4 | $1.29M | Buy |
2,037
+326
| +19% | +$206K | 0.33% | 85 |
|
|
2021
Q3 | $1.04M | Buy |
1,711
+199
| +13% | +$120K | 0.29% | 91 |
|
|
2021
Q2 | $844K | Buy |
+1,512
| New | +$844K | 0.24% | 100 |
|